FDANews
FDAnews Device Daily Bulletin

CardioFocus’ Endoscopic Ablator Gains CE Mark to Treat Atrial Fibrillation

March 27, 2019

CardioFocus received the CE Mark for its HeartLight X3, an endoscopic ablation system used to remove harmful tissue in the body and perform pulmonary vein isolation procedures.

The third-generation product combines a motor control system with laser energy and direct tissue visualization to block abnormal electric pathways responsible for atrial fibrillation.

Atrial fibrillation is a quivering or irregular heartbreak that can cause stroke, heart failure and other adverse events.

View today's stories